FDA Investigator Christopher J Cruciotti
Christopher J Cruciotti has inspections in 2 countries as of 21 Sep 2023. Christopher J Cruciotti has collaborated with a combined 1335 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
70
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Aaron L Morris,
Alois P Provost,
Alysia M Salonia,
Amy M Fitzpatrick,
Anne E Carpenter,
Ashley M Whitehurst,
Bradford L Swanson,
Brandy L Couillard,
Carr,
Charles R Clavet,
Clinton V Giustra,
Cullen T Wilson,
Dana A Razzano,
Darin S Wiegers,
Diane C Thibodeau,
Diane M Biron,
Diantha M Bleau,
Diantha M Turner,
Donna J Clevenger,
Douglas Florentino,
Eduardo L Rodriguez,
Emily J Schramm,
Eric C Schmitt,
Gale E Ryan,
Gena M Mckahan,
Gerard D Difiore,
Hill,
James K Mcnally,
James W Whitney,
Jamie S Mathews,
Janis S Gallagher,
Jason A Rossi,
Jason D Tenney,
Jeffrey R Alling,
Jessica I Newman,
John A Hollings,
John L Zaccone,
John P Shelton,
Jolene R Rearick Whitney,
Joseph B Cascio,
Joseph Foley,
Joseph R Haynes,
Joshua L Gibbs,
Joyce A Kellett,
Justine M Corson,
Kathleen E Mcafoose,
Laurie B Frazier,
Liz M Otero,
Mark R Mcclain,
Maryam Tabatabaie,
Maxim,
Michael P Mcpartlin,
Mikayla K Deardorff,
Nicholas J Scire,
Nichole B Murphy,
Osama A Khatib,
Pamela L Ogonowski,
Raymond M Lam,
Rebecca A Coleman,
Rebecca B Welch,
Rebecca C Maxim,
Richard F Hapke,
Richard G Fochesato,
Richard L Licari,
Richard W Skodinski,
Robert D Ogan,
Robert E Teel,
Rupa Pradhan,
Slater K Bartlett,
State Agency,
Stephen C Smith,
Terry C Kimball,
Thomas H Jenkins,
Thomas J Murphy,
Thomas Siebertz,
Tracy M Portelli,
Wendy A Johnecheck,
Wendy M Stone
Christopher J Cruciotti's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2017 | FDA 483 | Oakhurst Dairy Company - Form 483, 2017-11-13 |
September, 2018 | EIR | BRAVO! LLC - EIR, 2018-09-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more